InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-47.8%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Fitzpatrick Alexander A, Conseiller Juridique et Secrétaire. Officer active across 3 companies, notably Evofem Biosciences, Inc.. Cumulatively, 8 reports have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €154k. History available since 20 May 2021. The latest transaction was filed on 20 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Fitzpatrick Alexander A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
3,355 股Common StockSEC:0001398595-26-000004:0
100,000 股@ US$5.5878.3% 占其流量Common StockSEC:0001415889-25-014186:0
40,000 股@ US$3.62421.7% 占其流量Common StockSEC:0001209191-23-051073:0
标准退出：2023年12月27日 (T+90)
300,000 股0Common StockSEC:0001618835-22-000031:0
120,000 股0Common StockSEC:0001618835-22-000006:0
25,000 股@ US$0.38918.5% 占其流量Common StockSEC:0001618835-21-000273:0
标准退出：2022年3月20日 (T+90)
10,000 股@ US$1.02518.0% 占其流量Common StockSEC:0001618835-21-000146:0
标准退出：2021年9月8日 (T+90)
42,120 股@ US$0.8663.4% 占其流量Common StockSEC:0001618835-21-000137:0
8 条申报中的 8 条
About Fitzpatrick Alexander A
Alexander A. Fitzpatrick serves as General Counsel and Secretary for Evofem Biosciences, Inc. In this role, he is responsible for the company's legal matters and compliance. His expertise in corporate law is essential to ensure good governance at Evofem.
